{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T18:24:36Z","timestamp":1774203876391,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Chromatogr Sci"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1093\/chromsci\/bmw091","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T18:10:03Z","timestamp":1468347003000},"page":"1146-1152","source":"Crossref","is-referenced-by-count":20,"title":["HPTLC and Spectrophotometric Estimation of Febuxostat and Diclofenac Potassium in Their Combined Tablets"],"prefix":"10.1093","volume":"54","author":[{"given":"Fawzi A.","family":"El-Yazbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omayma A.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman I.","family":"El-Kimary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essam F.","family":"Khamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh E.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"2016071209425326000_54.7.1146.1","unstructured":"Sweetman S.C. ; Martindale, the complete drug reference, 37th ed. The Pharmaceutical Press, London, UK, (2011)."},{"key":"2016071209425326000_54.7.1146.2","unstructured":"O'Neil M.J. ; The Merck Index, 14th ed. Merck Research Laboratories, Whitehouse Station, NJ, USA, (2006)."},{"key":"2016071209425326000_54.7.1146.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep088"},{"key":"2016071209425326000_54.7.1146.4","first-page":"244","article-title":"Analytical method development and validation for simultaneous estimation of diclofenac potassium and febuxostat in tablet dosage forms","volume":"3","author":"Chaudhari","year":"2014","journal-title":"International Journal of Universal Pharmacy and Bio Sciences"},{"key":"2016071209425326000_54.7.1146.5","first-page":"2655","article-title":"A simple UV spectrophotometric method for the determination of febuxostat in bulk and pharmaceutical formulations","volume":"2","author":"Begga","year":"2011","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"key":"2016071209425326000_54.7.1146.6","first-page":"1002","article-title":"Spectrophotometric determination of drugs in bulk and pharmaceutical dosage forms by using tetracyanoethylene","volume":"6","author":"Srinivas","year":"2015","journal-title":"International Journal of Pharma Sciences and Research"},{"key":"2016071209425326000_54.7.1146.7","first-page":"1104","article-title":"Development and validation of RP-HPLC method for estimation of febuxostat in bulk and tablet dosage form","volume":"2","author":"Nageswara","year":"2012","journal-title":"International Journal of Research in Pharmacy and Chemistry"},{"key":"2016071209425326000_54.7.1146.8","first-page":"205","article-title":"A RP-HPLC method development and validation for the estimation of febuxostat in bulk and pharmaceutical dosage forms","volume":"3","author":"Kumar","year":"2012","journal-title":"International Research Journal of Pharmacy"},{"key":"2016071209425326000_54.7.1146.9","first-page":"1358","article-title":"A validated RP-HPLC method for the estimation of febuxostat in bulk drugs","volume":"4","author":"Muvvala","year":"2012","journal-title":"International Journal of PharmTech Research"},{"key":"2016071209425326000_54.7.1146.10","first-page":"137","article-title":"Reverse phase high performance liquid chromatographic estimation of anti-gout in pharmaceutical dosage form","volume":"3","author":"Nasare","year":"2012","journal-title":"International Journal of Pharmaceutical, Chemical and Biological Sciences"},{"key":"2016071209425326000_54.7.1146.11","first-page":"46","article-title":"Developed and validated reverse phase HPLC method for the determination of febuxostat in bulk and formulations","volume":"4","author":"Lakade","year":"2012","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences"},{"key":"2016071209425326000_54.7.1146.12","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bms192"},{"key":"2016071209425326000_54.7.1146.13","first-page":"671","article-title":"ICH guidance in practice: development of a validated stability-indicating high-performance liquid chromatographic assay method for febuxostat and degradation kinetic study in acid hydrolytic condition","volume":"4","author":"Sheth","year":"2013","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"key":"2016071209425326000_54.7.1146.14","first-page":"138","article-title":"Stress degradation studies and validation method for quantification of febuxostat in formulations by using RP-HPLC","volume":"4","author":"Rajyalakshmi","year":"2013","journal-title":"International Journal of Research in Pharmaceutical and Biomedical Sciences"},{"key":"2016071209425326000_54.7.1146.15","first-page":"228","article-title":"A stability indicating RP-HPLC method development for determination of febuxostat in tablet dosage form","volume":"1","author":"Reddy","year":"2013","journal-title":"Caribbean Journal of Science and Technology"},{"key":"2016071209425326000_54.7.1146.16","first-page":"405","article-title":"A stability-indicating RP-UPLC method for estimation of febuxostat and its impurities in bulk drugs and pharmaceutical dosage forms","volume":"3","author":"Molleti","year":"2013","journal-title":"American Journal of PharmaTech Research"},{"key":"2016071209425326000_54.7.1146.17","doi-asserted-by":"publisher","DOI":"10.1590\/S0103-50532005000600026"},{"key":"2016071209425326000_54.7.1146.18","first-page":"7","article-title":"Development of a spectrophotometric method for the assay of diclofenac potassium","volume":"2","author":"Naveed","year":"2015","journal-title":"Journal of Innovations in Pharmaceuticals and Biological Sciences"},{"key":"2016071209425326000_54.7.1146.19","first-page":"488","article-title":"Estimation of diclofenac sodium pellets (extended release) in commercial dosage forms using a simple and convenient spectrophotometric method","volume":"2","author":"Mandava","year":"2009","journal-title":"Rasayan Journal of Chemistry"},{"key":"2016071209425326000_54.7.1146.20","doi-asserted-by":"publisher","DOI":"10.1590\/S1984-82502013000300021"},{"key":"2016071209425326000_54.7.1146.21","first-page":"103","article-title":"HPLC evaluation of diclofenac in the various forms of therapeutic preparation","volume":"59","author":"Hanysova","year":"2005","journal-title":"Chemical Papers"},{"key":"2016071209425326000_54.7.1146.22","first-page":"467","article-title":"High performance liquid chromatographic method for the determination of diclofenac sodium in pharmaceutical preparations and in environmental samples","volume":"44","author":"Ahmed","year":"2011","journal-title":"Iraqi National Journal of Chemistry"},{"key":"2016071209425326000_54.7.1146.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2011.01.018"},{"key":"2016071209425326000_54.7.1146.24","first-page":"690","article-title":"Stability indicating HPLC method for simultaneous determination of diclofenac potassium, paracetamol and methocarbamol","volume":"2","author":"Amin","year":"2012","journal-title":"American Journal of PharmaTech Research"},{"key":"2016071209425326000_54.7.1146.25","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.1109-16"},{"key":"2016071209425326000_54.7.1146.26","unstructured":"The British Pharmacopeia. Her Majesty's Stationery Office, London, UK, (2016)."},{"key":"2016071209425326000_54.7.1146.27","unstructured":"The United States Pharmacopeia, Thirty-third edition, The National Formulary, Twenty-eighth edition. United States Pharmacopeial Convention, Inc., USA, (2011)."},{"key":"2016071209425326000_54.7.1146.28","unstructured":"The European pharmacopeia, 8th ed. The Directorate for the Quality of Medicines & Healthcare of the Council of Europe, France, (2014)."},{"key":"2016071209425326000_54.7.1146.29","first-page":"134","article-title":"Development of validated UV spectrophotometric methods for the simultaneous estimation of febuxostat and diclofenac potassium in tablet dosage form utilising simultaneous equation and absorbance ratio method","volume":"4","author":"Haripriya","year":"2013","journal-title":"International Journal of Pharma and Bio Sciences"},{"key":"2016071209425326000_54.7.1146.30","first-page":"268","article-title":"Development and validation of spectrophotometric method for simultaneous estimation of diclofenac potassium and febuxostat in tablet dosage forms","volume":"4","author":"Modi","year":"2013","journal-title":"Pharma Science Monitor"},{"key":"2016071209425326000_54.7.1146.31","first-page":"968","article-title":"Spectrophotometric determination of febuxostat and diclofenac potassium in their combined dosage form by simultaneous equation and first order derivative methods","volume":"6","author":"Derasari","year":"2013","journal-title":"Asian Journal of Research in Chemistry"},{"key":"2016071209425326000_54.7.1146.32","first-page":"103","article-title":"Validation of RP-HPLC for simultaneous estimation of febuxostat and diclofenac potassium in bulk drug and in bilayer tablet formulation","volume":"4","author":"Vaibhav","year":"2013","journal-title":"International Research Journal of Pharmacy"},{"key":"2016071209425326000_54.7.1146.33","doi-asserted-by":"publisher","DOI":"10.5155\/eurjchem.5.3.545-549.1066"},{"key":"2016071209425326000_54.7.1146.34","doi-asserted-by":"publisher","DOI":"10.1002\/dta.165"},{"key":"2016071209425326000_54.7.1146.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bfopcu.2013.12.001"},{"key":"2016071209425326000_54.7.1146.36","doi-asserted-by":"crossref","unstructured":"Srivastava M. ; High-Performance Thin-Layer Chromatography (HPTLC), Springer, NY, USA, (2011).","DOI":"10.1007\/978-3-642-14025-9"},{"key":"2016071209425326000_54.7.1146.37","unstructured":"ICH. Validation of Analytical Procedures: Text and Methodology Q2(R1). In International Conference on Harmonisation, Geneva, (2005). http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q2_R1\/Step4\/Q2_R1__Guideline.pdf (accessed April 20, 2015)."},{"key":"2016071209425326000_54.7.1146.38","unstructured":"Miller J.N. , Miller J.C. ; Statistics and chemometrics for analytical chemistry, 4th ed, Prentice Hall, Harlow, England, (2000)."},{"key":"2016071209425326000_54.7.1146.39","unstructured":"Armitage P. , Berry G. ; Statistical methods in medical research, 3rd ed. Blackwell Scientific Publications, Oxford, England, (1994)."},{"key":"2016071209425326000_54.7.1146.40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0039-9140(94)80048-0","article-title":"Simultaneous determination of ceftriaxone and streptomycin in mixture by \u2018ratio-spectra\u2019 2nd derivative and \u2018zero-crossing\u2019 3rd derivative spectrophotometry","volume":"5","author":"Morelli","year":"1994","journal-title":"Talanta"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:17:20Z","timestamp":1498328240000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article-lookup\/doi\/10.1093\/chromsci\/bmw091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,12]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1093\/chromsci\/bmw091"],"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmw091","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}